DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Esperion Therapeutics, Inc. (ESPR)
« Back to company indexESPR Chatter Timeline
Stock Ticker for ESPR
Most Active Tweeters for ESPR
| User | Tweets |
|---|---|
| @Tickeron | 14 |
| @ZolmaxNews | 4 |
| @Gambiste1 | 4 |
| @WatchlistN | 4 |
| @OlympiaReport | 4 |
Recent Tweets for ESPR
 |
@OlympiaReport Esperion Therapeutics $ESPR Trading Up 9.8% https://t.co/jaYuTZbKXL April 2nd 2020, 7:04pm |
 |
@tradersreport RT @Tickeron: $ESPR's 10-day Moving Average crossed below its 50-day Moving Average on March 3, 2020. View odds for this and other indicato… April 2nd 2020, 6:04pm |
 |
@Tickeron $ESPR's 10-day Moving Average crossed below its 50-day Moving Average on March 3, 2020. View odds for this and othe… https://t.co/me8CHGR3li April 2nd 2020, 6:04pm |
 |
@ThisLincolnian -$3.23 Earnings Per Share Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/nCUzagMKgw April 2nd 2020, 5:04am |
 |
@ZolmaxNews Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$3.23 Earnings Per Share https://t.co/2Dh5qjuCKH April 2nd 2020, 5:04am |
 |
@WatchlistN Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$3.23 Earnings Per Share https://t.co/TPcyHaFWdj April 2nd 2020, 5:04am |
 |
@AmericanBanking Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$3.23 Earnings Per Share https://t.co/ebxVg4AtyZ #stocks April 2nd 2020, 5:04am |
|
@Tickeron $ESPR's 10-day Moving Average moved below its 50-day Moving Average on March 3, 2020. View odds for this and other… https://t.co/XpGyLVWVjV April 1st 2020, 8:04pm |
|
@AmericanBanking Needham & Company LLC Reaffirms Buy Rating for Esperion Therapeutics $ESPR https://t.co/5mZi5w5Soi #stocks April 1st 2020, 7:04pm |
 |
@Gambiste1 RT @portefeuillefun: Bought 0.65k $ESPR at $30.04, now 0.8k #vssporte shares. April 1st 2020, 6:04pm |
 |
@portefeuillefun Bought 0.65k $ESPR at $30.04, now 0.8k #vssporte shares. April 1st 2020, 5:04pm |
|
@OlympiaReport Esperion Therapeutics $ESPR Receives Buy Rating from Needham & Company LLC https://t.co/wIHgWEaics April 1st 2020, 5:04pm |
 |
@timfris RT @_Zenil_: Sell the company $espr April 1st 2020, 1:04pm |
 |
@tradingbotnyse Stocks with greater movement, last 15 minutes $ESPR +/- 2.66% Esperion Therapeutics Inc. $ET +/- 2.56% Energy Tran… https://t.co/h6uQICHvXl April 1st 2020, 11:04am |
|
@AmericanBanking Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/IAvrJ4JCGE #stocks April 1st 2020, 9:04am |
 |
@dakotafinancial Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/pPqSwD6Dic April 1st 2020, 9:04am |
 |
@ConsumerFeed Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/h2HDd1nbSQ April 1st 2020, 9:04am |
 |
@TranscriptDaily Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/bxRoYGkhfl April 1st 2020, 9:04am |
|
@Gambiste1 RT @odibro: $ESPR initiated with a Buy at BofA. $50 PT April 1st 2020, 6:04am |
 |
@FireTrader05 $ESPR BofA analyst Geoff Meachem initiated coverage of Esperion with a Buy rating and $50 price target April 1st 2020, 6:04am |
|
@Gambiste1 RT @RNAiAnalyst: @semodough Probably 1 of the least important products to launch. And with #COVID19...forget about it. $ESPR April 1st 2020, 6:04am |
|
@Gambiste1 RT @semodough: Baml $ESPR US: Esperion Therapeutics: Reinstatement of Coverage - Highly awaited launch to re-engage investors despite macro… April 1st 2020, 6:04am |
 |
@odibro $ESPR initiated with a Buy at BofA. $50 PT April 1st 2020, 6:04am |
 |
@RNAiAnalyst @semodough Probably 1 of the least important products to launch. And with #COVID19...forget about it. $ESPR April 1st 2020, 6:04am |
 |
@semodough Baml $ESPR US: Esperion Therapeutics: Reinstatement of Coverage - Highly awaited launch to re-engage investors desp… https://t.co/9xukJZ27sO April 1st 2020, 6:04am |
|
@WatchlistN Esperion Therapeutics $ESPR Given “Buy” Rating at Needham & Company LLC https://t.co/2bwueXTSoz April 1st 2020, 3:04am |
|
@Tickeron $ESPR's 10-day Moving Average broke below its 50-day Moving Average on March 3, 2020. View odds for this and other… https://t.co/VME2bcbxLV March 31st 2020, 6:03pm |
 |
@AniuStudent Actually, my point is, at least 4 confused Twitter investors (aka so many), $ESPR just lost a competitor. & b4 the… https://t.co/EcmLGW2Sgw March 31st 2020, 10:03am |
 |
@_Zenil_ Sell the company $espr March 31st 2020, 10:03am |
|
@WatchlistN Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/4HKJFg9tZy March 31st 2020, 6:03am |
 |
@poorcoach44 RT @EsperionInc: $ESPR announces commercial availability of the NEXLETOL™ (bempedoic acid) tablet and pledges a conscientious launch during… March 30th 2020, 10:03pm |
 |
@Briefingcom $ESPR: Esperion Therapeutics announces availability of NEXLETOL https://t.co/dMvPOvJcCU March 30th 2020, 6:03pm |
|
@Tickeron $ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and o… https://t.co/4U746Yzn6M March 30th 2020, 4:03pm |
 |
@EsperionInc $ESPR announces commercial availability of the NEXLETOL™ (bempedoic acid) tablet and pledges a conscientious launch… https://t.co/ffmu4QTQfd March 30th 2020, 4:03pm |
 |
@otcdynamics $ESPR Esperion Announces Commercial Availability of the NEXLETOL™ (bempedoic acid) Tablet and Pledges a C https://t.co/ilGa3abPpn March 30th 2020, 4:03pm |
|
@timfris @arenella1 @semodough $ESPR has been taking an absolute beating too. March 30th 2020, 3:03pm |
 |
@MLind_Benco RT @AniuStudent: $ESPR is a cheap, oral pill, known to reduce inflammation, & LDL at a reduced level compared to #PCSK9 injectables-either… March 30th 2020, 11:03am |
|
@MLind_Benco $ESPR cholesterol pill that is less expensive, effective, safe and good for patients who cannot tolerate statin dru… https://t.co/yu86pCu73J March 30th 2020, 11:03am |
 |
@dailypoliticaln Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/SfWfWOGB2V March 30th 2020, 6:03am |
|
@dailypoliticaln Esperion Therapeutics $ESPR Raised to Buy at Zacks Investment Research https://t.co/U0ORUIfdOM March 30th 2020, 6:03am |
 |
@stocknewstimes Esperion Therapeutics $ESPR Raised to Buy at Zacks Investment Research https://t.co/gPuZIgCmMQ March 30th 2020, 5:03am |
|
@dakotafinancial Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/EuUuZpfgzW March 30th 2020, 5:03am |
|
@ZolmaxNews Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/wZfJJ9bKPl March 30th 2020, 5:03am |
|
@ConsumerFeed Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/KSl1Loytwj March 30th 2020, 5:03am |
|
@Tickeron $ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and o… https://t.co/vHzjUSuAqV March 29th 2020, 5:03pm |
 |
@HealthcareBeat Man Group Grows Stake in Esperion Therapeutics Inc $ESPR https://t.co/qiEX4Cbcmm March 29th 2020, 3:03pm |
 |
@gcassidy718 $ESPR major stock movement -5.62 % change recently https://t.co/ZJ7rwkXcgV March 29th 2020, 3:03pm |
 |
@BlueBioNow $ESPR price movement -5.62 % https://t.co/ZFif3yGLgm March 28th 2020, 8:03pm |
|
@Tickeron $ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and o… https://t.co/d03QdN2Mgc March 28th 2020, 5:03pm |
 |
@stevedoc22 Question: is $ESPR still planning to launch Nexletol during a pandemic lockdown? Should we have concerns about this… https://t.co/y5MG8sXDzP March 28th 2020, 2:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.